This study aim to identify the expression of resistance to antitumor immunity on cellular and tissue alterations predictive of Human Papillomavirus infection as well as to establish the relationship between this resistance and the grades of Intraepithelial neoplasms of the cervix in patients from Lubumbashi and Kinshasa in the Democratic Republic of Congo. This is a study on cervical biopsies whose diagnosis of intraepithelial neoplasia was confirmed by a routine histopathological examination in two pathology laboratories in the Democratic Republic of Congo, or the laboratory of Lubumbashi and the LEBOMA laboratory of Kinshasa. The paraffin blocks were selected during a period from March 2017 to March 2020 at the laboratory of Lubumbashi and at the LEBOMA laboratory in Kinshasa. Laboratory manipulations were carried out at the molecular pathology unit of the LEBOMA Pathological Anatomy and Cytology Cabinet in Kinshasa. Papillomavirus infection was retained by the presence of predictive cellular and tissue alterations. The expression of PD-L1 signifies resistance to anti-tumor immunity. The following results were observed; A total of 50 cases of intraepithelial neoplasia were recorded in a set of 107 patients with cervical lesions, i.e. a frequency of 46.7%. The cytological and histological alterations predictive of papillomavirus infection were observed in the following proportions: For cytological changes; koilocytosis was present in 92%, bi-nucleation was observed in 24% and dyskeratosis was identified in 46%, ie 46, 12 and 23 cases, respectively, out of 50 cases of cervical neoplasia recorded. The proportions of histological alterations are presented as follows: 62% of papillomatosis, 86% of acanthosis, 54% of basal hyperplasia and 34% of intraepithelial capillaries, i.e. 31, 43, 27 and 17 cases out of respectively. The 50 cases of intraepithelial neoplasia of the cervix recorded. PD-L1 expression was observed in 16 cases out of all intraepithelial neoplasia, ie 32% of cases. PD-L1 is mainly expressed in high-grade intraepithelial neoplasias, i.e. 81.25% 95% CI=54.35-95.95 and those involving bi-nucleation (OR=26.66 95% CI=4, 63-153.57, Fisher exact, p<0.01), the intraepithelial capillaries or 37.5%; 95% CI=15.20-64.57. It emerges from this study the expression of PD-L1 is not uniform over all the cyto-histological alterations predictive of human papillomavirus infection during neoplasias. intraepithelial of the cervix, but it is much more expressed in high-grade intraepithelial neoplasias and in those comprising the predictive alterations of Papillomavirus infection like the bi-nucleation and the intraepithelial capillary.
| Published in | International Journal of Clinical Oncology and Cancer Research (Volume 5, Issue 4) |
| DOI | 10.11648/j.ijcocr.20200504.12 |
| Page(s) | 82-92 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Intra-Epithelial Neoplasia, HPV, PD-L1
| [1] | Malagón T, Volesky KD, Bouten S, Laprise C, El-Zein M, Franco EL. Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: systematic review and meta-analysis. Int J Cancer. 2020. |
| [2] | Riccio DA, Maeda-Chubachi T, Messersmith E, Geer C. Nitric oxide as a topical treatment for cervical intraepithelial neoplasia caused by high-risk human papillomavirus infection. Med Res Arch. 2020; 8 (6). |
| [3] | Escobar N, Plugge E. Prevalence of human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer in imprisoned women worldwide: a systematic review and meta-analysis. J Epidemiol Community Health. 2020; 74 (1): 95–102. |
| [4] | Gupta SM, Mania-Pramanik J. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis. J Biomed Sci. 2019; 26 (1): 28. |
| [5] | von Knebel Doeberitz M, Cubie H, Broker TR, Jenkins D. Linking Human Papillomavirus to Human Cancer and Understanding Its Carcinogenic Mechanisms. In: Human Papillomavirus. Elsevier; 2020. p. 17–39. |
| [6] | He C, Lv X, Huang C, Angeletti PC, Hua G, Dong J, et al. A human papillomavirus-independent cervical cancer animal model reveals unconventional mechanisms of cervical carcinogenesis. Cell Rep. 2019; 26 (10): 2636–2650. |
| [7] | Vonsky M, Shabaeva M, Runov A, Lebedeva N, Chowdhury S, Palefsky JM, et al. Carcinogenesis associated with human papillomavirus infection. Mechanisms and potential for immunotherapy. Biochem Mosc. 2019; 84 (7): 782–799. |
| [8] | Chen L, Sun M, Shi H, He Q, Liu D. Association of human papillomavirus L1 capsid protein with koilocytosis, expression of p16, and Ki-67, and its potential as a prognostic marker for cervical intraepithelial neoplasia. Anal Quant Cytopathol Histopathol. 2013; 35 (3): 139–145. |
| [9] | Yoon HJ, Jeong M, Ki EY, Lee SJ, Lee YS. EP345 Human papillomavirus L1 capsid protein and HPV test as a biomarker for cervical intraepithelial neoplasia 2+ in women with persistent ASCUS/LSIL cervical cytology. BMJ Specialist Journals; 2019. |
| [10] | Seresht LM. EP368 Prognostic value of KI6 biomarker in predict short time prognosis of low grade cervical intraepithelial neoplasia in HPV negative and positive patient. BMJ Specialist Journals; 2019. |
| [11] | Yang F, Cui Z, Liao Y, Tian R, Fan W, Jin Z, et al. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women. Cancer Biomark. 2020; (Preprint): 1–10. |
| [12] | Ara R, Pervin S, Khatun S, Shahera U, Sultana M, Aktar MN. Low-Cost Molecular Biomarker HPV-16/18 E6 Oncoprotein Expression in Cervical Intraepithelial Neoplasia (CIN) and Cervical Cancer with Its Relation with Severity of Neoplastic State. Indian J Gynecol Oncol. 2020; 18 (3): 1–5. |
| [13] | Didier M, Veronique K, Abdon M, Prosper K, Julien I. Cervical Intra-Epithelial Neoplasia: Index of Papillomavirus Infection and Histopathological Grade in Lubumbashi Patients. Int J Clin Oncol Cancer Res. 2019; 4 (3): 29. |
| [14] | Amaro-Filho SM, Gradissimo A, Usyk M, Moreira FC, de Almeida LM, Moreira MA, et al. HPV73 a nonvaccine type causes cervical cancer. Int J Cancer. 2020; 146 (3): 731–738. |
| [15] | Carcopino X. Citología cervical y conducta práctica en caso de frotis anormal. EMC-Ginecol-Obstet. 2019; 55 (1): 1–11. |
| [16] | Pereira-Caldeira NMV, Góes FGB, de Almeida-Cruz MCM, de Souza Caliari J, Pereira-Ávila FMV, Gir E. Quality of Life for Women with Human Papillomavirus-induced Lesions. Rev Bras Ginecol E ObstetríciaRBGO Gynecol Obstet. 2020; 42 (04): 211–217. |
| [17] | Wu SC, Canarte V, Beeravolu H, Grace M, Sharma S, Munger K. Finding How Human Papillomaviruses Alter the Biochemistry and Identity of Infected Epithelial Cells. In: Human Papillomavirus. Elsevier; 2020. p. 53–65. |
| [18] | Salim RC, Lima TM, Heinke T, Prigenzi KC, Speck NMG, Focchi GR. Cervical squamous intraepithelial lesions grades 1 and 2: value of an alternative morphological classification and of p16 immunohistochemistry in the prediction of clinical outcome. J Bras Patol E Med Lab. 2017; 53 (5): 313–319. |
| [19] | GOULART APS, GONÇALVES MAG, DA-SILVA VD. Evaluation of Telomerase (hTert), Ki67 and p16ink4a expressions in low and high-grade cervical intraepithelial lesions. Rev Colégio Bras Cir. 2017; 44 (2): 131–139. |
| [20] | de Melo FLP, Lancellotti CLP, da Silva MALG. Expression of the immunohistochemical markers p16 and ki-67 and their usefulness in the diagnosis of cervical intraepithelial neoplasms. Rev Bras Ginecol E ObstetríciaRBGO Gynecol Obstet. 2016; 38 (02): 082–087. |
| [21] | Han C, Zhao F, Wan C, He Y, Chen Y. Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions. Oncol Lett. 2020; 20 (1): 884–892. |
| [22] | WANG H, JIN Y, NI C, TIAN X, WANG W, ZHAO Y. Correlation between ER, PR, P53, Ki67 Expression and High-Risk HPV Infection in Patients with Different Levels of Cervical Intraepithelial Neoplasia. Indian J Pharm Sci. 2020; 82 (3): 1–7. |
| [23] | Kawashita S, Matsuda K, Kondo H, Kitajima Y, Hasegawa Y, Shimada T, et al. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16INK4a Expression. Cancer Control. 2020; 27 (1): 1073274819901170. |
| [24] | Zhao J, Zhu J, Guo J, Zhu T, Zhong J, Liu M, et al. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women. J Med Virol. 2020; 92 (3): 372–381. |
| [25] | Vogelsang TL, Schmoeckel E, Kuhn C, Blankenstein T, Temelkov M, Heidegger H, et al. Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation. J Cancer Res Clin Oncol. 2020; 1–9. |
| [26] | Baba S, Taguchi A, Kawata A, Hara K, Eguchi S, Mori M, et al. Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia. Virol J. 2020; 17 (1): 1–10. |
| [27] | Farghaly SA. Immunotherapy for Precancerous Lesions of the Uterine Cervix. In: Uterine Cervical Cancer. Springer; 2019. p. 107–140. |
| [28] | Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The host-microbe interplay in human papillomavirus-induced carcinogenesis. Microorganisms. 2019; 7 (7): 199. |
| [29] | Kerr PS, Freedland SJ, Williams SB. The current status of molecular biomarkers in patients with metastatic urothelial carcinoma of the bladder. Taylor & Francis; 2020. |
| [30] | Evans ET, Castellano T, Brown AS, Dvorak J, Henson CE, Gunderson CC. The Effect of BMI on Radiation Dosing And Survival In Patients With Locally Advanced Cervical Cancer. Gynecol Oncol. 2020; 156 (3): e9–e10. |
| [31] | Marcq* G, Souhami L, Cury F, Aprikian A, Tanguay S, Vanhuyse M, et al. MP61-08 A PHASE I/II TRIAL OF TRANSURETHRAL SURGERY FOLLOWED BY A COMBINATION OF ATEZOLIZUMAB AN ANTI-PDL-1 (MPDL3280A) WITH TRIMODAL THERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER. J Urol. 2020; 203 (Supplement 4): e938–e938. |
| [32] | Walankiewicz M, Grywalska E, Korona-G\lowniak I, Rolinski J, Kotarski J. Alteration of the PD-1/PD-L1 axis in cervical intraepithelial neoplasia-preliminary study. Eur J Obstet Gynecol Reprod Biol. 2019; 234: e76. |
| [33] | Mezache L, Paniccia B, Nyinawabera A, Nuovo GJ. Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers. Mod Pathol. 2015; 28 (12): 1594–1602. |
| [34] | Yang W, Lu Y-P, Yang Y-Z, Kang J-R, Jin Y-D, Wang H-W. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status. J Obstet Gynaecol Res. 2017; 43 (10): 1602–1612. |
| [35] | Chinn Z, Stoler MH, Mills AM. PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy. Histopathology. 2019; 74 (2): 256–268. |
| [36] | Fimiani M, Mazzatenta C, Biagioli M, Andreassi L. Vulvar squamous papillomatosis and human papillomavirus infection. A polymerase chain reaction study. Arch Dermatol Res. 1993; 285 (5): 250–254. |
| [37] | Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012; 30: F34–F54. |
| [38] | Didier M, Véronique K, Philippe M, Abdon M, Joseph C, Prosper K, et al. Human Papillomavirus and Cervical Intra-Epithelial Neoplasia: Epidemiological and Cytological Study in Lubumbashi Women. Int J Clin Oncol Cancer Res. 2019; 4 (1): 1. |
| [39] | Cao L, Sun P-L, Yao M, Chen S, Gao H. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis. Hum Pathol. 2017; 65: 194–200. |
| [40] | Siebers AG, van der Linden H, Vedder JEM, Bekkers RLM, Melchers WLG, Bulten J. Presence of koilocytosis in low-grade smears of high-risk HPV-positive women is a negative predictor for cervical intraepithelial neoplasia grade 3 or more. Cytopathology. 2018; 29 (3): 275–280. |
| [41] | Park KJ. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification. Histopathology. 2020; 76 (1): 112–127. |
| [42] | Vrdoljak-Mozetič D, Krašević M, Verša Ostojić D, Štemberger-Papić S, Rubeša-Mihaljević R, Bubonja-Šonje M. HPV 16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions. Cytopathology. 2015; 26 (1): 10–18. |
| [43] | Gayatree A, Tanveer N, Arora VK, Arora V. Are Histomorphological Features Predictive of p16 Immunopositivity Different for Oral and Oropharyngeal Squamous Cell Carcinoma? Indian J Surg Oncol. 2020; 11 (2): 248–255. |
| [44] | Falcón MF, Paradeda ME, Kamermann FG, Maldonado V, Díaz L, Cardinal L. Immunohistochemistry of p16 and p53 in vulvar cancer. Medicina (Mex). 2020; 80 (2): 127–133. |
| [45] | Katumabayi JC, et al. Intraepithelial Neoplasias of uterine cervix in the Congolese in Kinshasa: interest of immunohistochimical biomarker. Ann africaines de medecine; Mai-2020 |
| [46] | Krause KA, Butler SL. Koilocytosis. In: StatPearls [Internet]. StatPearls Publishing; 2018. |
| [47] | Eble JN, Tavassoli FA, Devilee P. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Iarc; 2003. |
| [48] | Tavassoli FA. Pathology and genetics of tumours of the breast and female genital organs. World Hhealth Organ Classif Tumours. 2003. |
| [49] | Smith J, Robida MD, Acosta K, Vennapusa B, Mistry A, Martin G, et al. Quantitative and qualitative characterization of two PD-L1 clones: SP263 and E1L3N. Diagn Pathol. 2016; 11 (1): 1–9. |
| [50] | Silva NNT, Sabino A de P, Tafuri A, Lima AA. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women. BMC Med Genet. 2019 Jun 6; 20 (1): 100. |
| [51] | Didier M, Phillipe M, Abdon M, Julien I. Cervical smears: morphological and epidemiological study for intra-epithelial neoplasia in Lubumbashi. Int J Clin Oncol Cancer Res. 2018; 3 (4): 55–58. |
| [52] | Attya AM, Ali AE, AbdelSalam HS, Abdelwahab MM. Frequency of Cervical Intra-epithelial Neoplasia in Oral Contraceptive Pills Users in Zagazig University Hospitals. Zagazig Univ Med J. 2020 Jul 1; 26 (4): 590–7. |
| [53] | Paluku JL, Carter TE, Lee M, Bartels SA. Massive single visit cervical pre-cancer and cancer screening in eastern Democratic Republic of Congo. BMC Womens Health. 2019 Mar 4; 19 (1): 43. |
| [54] | Utoo. Cervical intraepithelial neoplasia: Prevalence, risk factors, and utilization of screening services among an urban population in Nigeria [Internet]. [cited 2020 Jul 21]. Available from: http://www.tjogonline.com/article.asp?issn=0189-5117; year=2016; volume=33; issue=3; spage=279; epage=283; aulast=Utoo. |
| [55] | Sanad AS, Kamel HH, Hasan MM. Prevalence of cervical intraepithelial neoplasia (CIN) in patients attending Minia Maternity University Hospital. Arch Gynecol Obstet. 2014 Jun; 289 (6): 1211–7. |
| [56] | Adekunle OO. Prevalence of cervical intraepithelial neoplasia in Zaria. Ann Afr Med. 2010; 9 (3). |
| [57] | Ceccato Junior BPV, Guimarães MDC, Lopes APC, Nascimento LF, Novaes LM, Castillo DM del, et al. Incidence of Cervical Human Papillomavirus and Cervical Intraepithelial Neoplasia in Women with Positive and Negative HIV Status. Rev Bras Ginecol E Obstetrícia. 2016 May; 38 (5): 231–8. |
| [58] | Wang X, Zeng Y, Huang X, Zhang Y. Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China [Internet]. Vol. 2018, BioMed Research International. Hindawi; 2018 [cited 2020 Jul 21]. p. e2897937. Available from: https://www.hindawi.com/journals/bmri/2018/2897937/. |
| [59] | Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P, Qiao Y, et al. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018 Jan 1; 5 (1): e45–58. |
| [60] | Zhao S, Zhao X, Hu S, Lu J, Duan X, Zhang X, et al. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China. Chin J Cancer Res. 2019 Aug; 31 (4): 663–72. |
| [61] | Ma L, Bian M-L, Cheng J-Y, Xiao W, Hao M, Zhu J, et al. Hybrid capture II for high-risk human papillomavirus DNA testing to detect cervical precancerous lesions: A qualitative and quantitative study. Exp Ther Med. 2010 Jan 1; 1 (1): 193–8. |
| [62] | Na K, Sung J-Y, Kim H-S. Clinicopathological Characteristics of High-grade Squamous Intraepithelial Lesions Involving Condyloma Acuminatum. Anticancer Res. 2018 Jan 3; 38 (3): 1767–74. |
| [63] | Missaoui N, Trabelsi A, Hmissa S, Fontanière B, Yacoubi MT, Mokni M, et al. p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women. Pathol-Res Pract. 2010; 206 (8): 550–555. |
| [64] | Mandic A, UsajKnezevic S, KapiclIvkovic T. Tissue expression of VEGF in cervical intraepithelial neoplasia and cervical cancer. J BUON. 2014; 19 (4): 958–64. |
| [65] | No JH, Jo H, Kim S-H, Park I-A, Kang D, Lee CH, et al. Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia. Ann N Y Acad Sci. 2009; 1171 (1): 100. |
| [66] | Guillaud M, Buys TPH, Carraro A, Korbelik J, Follen M, Scheurer M, et al. Evaluation of HPV Infection and Smoking Status Impacts on Cell Proliferation in Epithelial Layers of Cervical Neoplasia. PLOS ONE. 2014 Sep 11; 9 (9): e107088. |
| [67] | Cabibi D, Giovannelli L, Martorana A, Migliore MC, Tripodo C, Campione M, et al. Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions. 2007. |
| [68] | Roux C. Activité immunosuppressive des cellules stromales mésenchymateuses dérivées de cellules souches pluripotentes induites humaines: induction de lymphocytes T régulateurs in vitro et in vivo et expression de PD-L1 [PhD Thesis]. 2018. |
| [69] | Vassilakopoulou M, Avgeris M, Velcheti V, Kotoula V, Rampias T, Chatzopoulos K, et al. Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma. Clin Cancer Res. 2016; 22 (3): 704–713. |
| [70] | Beyrend G, van der Gracht E, Yilmaz A, van Duikeren S, Camps M, Höllt T, et al. PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors. J Immunother Cancer. 2019; 7 (1): 1–14. |
| [71] | Tsang JY, Au W-L, Lo K-Y, Ni Y-B, Hlaing T, Hu J, et al. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients. Breast Cancer Res Treat. 2017; 162 (1): 19–30. |
| [72] | Winkler B, Crum CP, Fujii T, Ferenczy A, Boon M, Braun L, et al. Koilocytotic lesions of the cervix. The relationship of mitotic abnormalities to the presence of papillomavirus antigens and nuclear dna content. Cancer. 1984; 53 (5): 1081–7. |
| [73] | Etchebehere RM, Almeida ÉCS, Côbo EC, Duque AC da R, Murta EFC, Adad SJ, et al. Comparison of Classical and Secondary Cytologic Criteria Relative to Hybrid Capture for Diagnosing Cervical-vaginal Infection by Human Papillomavirus. Rev Bras Ginecol E Obstetrícia. 2016 Jan; 38 (1): 41–6. |
| [74] | Washiya K, Motoi M, Kobayashi T, Yoshioka H, Watanabe J. Significance of binucleated cells with compression in atypical squamous cells of undetermined significance. Acta Cytol. 2013; 57 (6): 599–603. |
| [75] | Win KP, Kitjaidure Y, Hamamoto K, Myo Aung T. Computer-Assisted Screening for Cervical Cancer Using Digital Image Processing of Pap Smear Images. Appl Sci. 2020 Jan; 10 (5): 1800. |
| [76] | Meziani S, Haoud K, Mehida H, Menadi N, Chenni FZ, Bekhaled I, et al. Epidemiological Approach and Precocious Diagnosis of Precancerous Cervical Lesion in Sidi Bel Abbes Region (North-West of Algeria). J Drug Deliv Ther. 2020; 10 (1-s): 72–78. |
| [77] | Kir G, Sarbay BC, Seneldir H. The significance of parakeratosis alone in cervicovaginal cytology of turkish women. Diagn Cytopathol. 2017; 45 (4): 297–302. |
| [78] | Bedin R, Gasparin VA, de Brito Pitilin É. Fatores associados às alterações cérvico-uterinas de mulheres atendidas em um município polo do oeste catarinense Factors associated to uterine-cervix changes in women assisted in a pole town in western Santa Catarina. Rev Pesqui Cuid É Fundam Online. 2017; 9 (1): 167–174. |
| [79] | Shetty R, Hebbar A, Kulkarni N. Pattern of Cervical Cytology using Papanicolaou Stain: An Experience from a Tertiary Hospital. Call Editor Board Memb. 2020; 13 (1): 83. |
| [80] | Muntean M. Cytological identification of the (pre) cancerous cervical lesions within a clinically asymptomatic female population. Curr Health Sci J. 2009; 35: 176–179. |
| [81] | Hong SR, Kim BM, Kim HS, Chun YK, Kim HS. Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear. Korean J Pathol. 2010; 44 (5): 528. |
| [82] | Hunter C, Duggan MA, Duan Q, Power P, Gregoire J, Nation J. Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H. Cytopathology. 2009; 20 (1): 17–26. |
| [83] | Zhang H, Zhang T, You Z, Zhang Y. Positive Surgical Margin, HPV Persistence, and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization. PLOS ONE. 2015 Dec 1; 10 (12): e0142868. |
| [84] | Curley J, Conaway MR, Chinn Z, Duska L, Stoler M, Mills AM. Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia. Mod Pathol. 2020 Jun; 33 (6): 1182–92. |
| [85] | Liu C, Lu J, Tian H, Du W, Zhao L, Feng J, et al. Increased expression of PD‑L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity. Mol Med Rep. 2017 Mar 1; 15 (3): 1063–70. |
| [86] | Nuovo G, Schwartz Z, Magro C. A comparison of the detection of biomarkers in infections due to low risk versus high-risk human papillomavirus types. Ann Diagn Pathol. 2019 Aug 1; 41: 57–61. |
| [87] | Khalbuss WE, Pantanowitz L, Monaco SE. Cytomorphology of unusual primary tumors in the Pap test. Cytojournal. 2013; 10. |
| [88] | Stoler MH, Jenkins D, Bergeron C. The Pathology of Cervical Precancer and Cancer and its importance in clinical practice. In: Human Papillomavirus. Elsevier; 2020. p. 85–109. |
| [89] | Léonard B, Kridelka F, Delbecque K, Goffin F, Demoulin S, Doyen J, et al. A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma. BioMed Res Int. 2014; 2014. |
| [90] | de Oliveira GG, Eleutério RMN, Barbosa R de CC, de Almeida PRC, Eleutério Jr J. Atypical squamous cells: cytopathological findings and correlation with HPV genotype and histopathology. Acta Cytol. 2018; 62 (5–6): 386–392. |
| [91] | Leonardo E, Bardales RH. Exfoliative Cytology. In: Leonardo E, Bardales RH, editors. Practical Immunocytochemistry in Diagnostic Cytology [Internet]. Cham: Springer International Publishing; 2020 [cited 2020 Aug 7]. p. 41–67. Available from: https://doi.org/10.1007/978-3-030-46656-5_3. |
| [92] | Tambas M, Altun M, Tural D. Human papillomavirus in head and neck cancer. Hum Papillomavirus Res Glob Perspect. 2016; 255. |
| [93] | Foy J-P, Bertolus C, Boutolleau D, Agut H, Gessain A, Herceg Z, et al. Arguments to Support a Viral Origin of Oral Squamous Cell Carcinoma in Non-Smoker and Non-Drinker Patients. Front Oncol. 2020; 10: 822. |
| [94] | Tracht J, Robinson BS, Krasinskas AM. Pathology of Premalignant and Malignant Disease of the Esophagus. In: Esophageal Cancer. Springer; 2020. p. 61–81. |
| [95] | Sancakli Usta C, Altun E, Afsar S, Bulbul CB, Usta A, Adalı E. Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence. Infect Agent Cancer. 2020 Jul 17; 15 (1): 47. |
APA Style
Mwenze Didier, Kyabu Véronique, Bokambandja Fabrice, Kasamba Eric, Mukalay Abdon, et al. (2020). Cervical Neoplasia: Papillomavirus Infection and Resistance to Anti Tumor Immunity. International Journal of Clinical Oncology and Cancer Research, 5(4), 82-92. https://doi.org/10.11648/j.ijcocr.20200504.12
ACS Style
Mwenze Didier; Kyabu Véronique; Bokambandja Fabrice; Kasamba Eric; Mukalay Abdon, et al. Cervical Neoplasia: Papillomavirus Infection and Resistance to Anti Tumor Immunity. Int. J. Clin. Oncol. Cancer Res. 2020, 5(4), 82-92. doi: 10.11648/j.ijcocr.20200504.12
AMA Style
Mwenze Didier, Kyabu Véronique, Bokambandja Fabrice, Kasamba Eric, Mukalay Abdon, et al. Cervical Neoplasia: Papillomavirus Infection and Resistance to Anti Tumor Immunity. Int J Clin Oncol Cancer Res. 2020;5(4):82-92. doi: 10.11648/j.ijcocr.20200504.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcocr.20200504.12,
author = {Mwenze Didier and Kyabu Véronique and Bokambandja Fabrice and Kasamba Eric and Mukalay Abdon and Kalenga Prosper and Lebwaze Bienvenu},
title = {Cervical Neoplasia: Papillomavirus Infection and Resistance to Anti Tumor Immunity},
journal = {International Journal of Clinical Oncology and Cancer Research},
volume = {5},
number = {4},
pages = {82-92},
doi = {10.11648/j.ijcocr.20200504.12},
url = {https://doi.org/10.11648/j.ijcocr.20200504.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20200504.12},
abstract = {This study aim to identify the expression of resistance to antitumor immunity on cellular and tissue alterations predictive of Human Papillomavirus infection as well as to establish the relationship between this resistance and the grades of Intraepithelial neoplasms of the cervix in patients from Lubumbashi and Kinshasa in the Democratic Republic of Congo. This is a study on cervical biopsies whose diagnosis of intraepithelial neoplasia was confirmed by a routine histopathological examination in two pathology laboratories in the Democratic Republic of Congo, or the laboratory of Lubumbashi and the LEBOMA laboratory of Kinshasa. The paraffin blocks were selected during a period from March 2017 to March 2020 at the laboratory of Lubumbashi and at the LEBOMA laboratory in Kinshasa. Laboratory manipulations were carried out at the molecular pathology unit of the LEBOMA Pathological Anatomy and Cytology Cabinet in Kinshasa. Papillomavirus infection was retained by the presence of predictive cellular and tissue alterations. The expression of PD-L1 signifies resistance to anti-tumor immunity. The following results were observed; A total of 50 cases of intraepithelial neoplasia were recorded in a set of 107 patients with cervical lesions, i.e. a frequency of 46.7%. The cytological and histological alterations predictive of papillomavirus infection were observed in the following proportions: For cytological changes; koilocytosis was present in 92%, bi-nucleation was observed in 24% and dyskeratosis was identified in 46%, ie 46, 12 and 23 cases, respectively, out of 50 cases of cervical neoplasia recorded. The proportions of histological alterations are presented as follows: 62% of papillomatosis, 86% of acanthosis, 54% of basal hyperplasia and 34% of intraepithelial capillaries, i.e. 31, 43, 27 and 17 cases out of respectively. The 50 cases of intraepithelial neoplasia of the cervix recorded. PD-L1 expression was observed in 16 cases out of all intraepithelial neoplasia, ie 32% of cases. PD-L1 is mainly expressed in high-grade intraepithelial neoplasias, i.e. 81.25% 95% CI=54.35-95.95 and those involving bi-nucleation (OR=26.66 95% CI=4, 63-153.57, Fisher exact, p<0.01), the intraepithelial capillaries or 37.5%; 95% CI=15.20-64.57. It emerges from this study the expression of PD-L1 is not uniform over all the cyto-histological alterations predictive of human papillomavirus infection during neoplasias. intraepithelial of the cervix, but it is much more expressed in high-grade intraepithelial neoplasias and in those comprising the predictive alterations of Papillomavirus infection like the bi-nucleation and the intraepithelial capillary.},
year = {2020}
}
TY - JOUR T1 - Cervical Neoplasia: Papillomavirus Infection and Resistance to Anti Tumor Immunity AU - Mwenze Didier AU - Kyabu Véronique AU - Bokambandja Fabrice AU - Kasamba Eric AU - Mukalay Abdon AU - Kalenga Prosper AU - Lebwaze Bienvenu Y1 - 2020/11/23 PY - 2020 N1 - https://doi.org/10.11648/j.ijcocr.20200504.12 DO - 10.11648/j.ijcocr.20200504.12 T2 - International Journal of Clinical Oncology and Cancer Research JF - International Journal of Clinical Oncology and Cancer Research JO - International Journal of Clinical Oncology and Cancer Research SP - 82 EP - 92 PB - Science Publishing Group SN - 2578-9511 UR - https://doi.org/10.11648/j.ijcocr.20200504.12 AB - This study aim to identify the expression of resistance to antitumor immunity on cellular and tissue alterations predictive of Human Papillomavirus infection as well as to establish the relationship between this resistance and the grades of Intraepithelial neoplasms of the cervix in patients from Lubumbashi and Kinshasa in the Democratic Republic of Congo. This is a study on cervical biopsies whose diagnosis of intraepithelial neoplasia was confirmed by a routine histopathological examination in two pathology laboratories in the Democratic Republic of Congo, or the laboratory of Lubumbashi and the LEBOMA laboratory of Kinshasa. The paraffin blocks were selected during a period from March 2017 to March 2020 at the laboratory of Lubumbashi and at the LEBOMA laboratory in Kinshasa. Laboratory manipulations were carried out at the molecular pathology unit of the LEBOMA Pathological Anatomy and Cytology Cabinet in Kinshasa. Papillomavirus infection was retained by the presence of predictive cellular and tissue alterations. The expression of PD-L1 signifies resistance to anti-tumor immunity. The following results were observed; A total of 50 cases of intraepithelial neoplasia were recorded in a set of 107 patients with cervical lesions, i.e. a frequency of 46.7%. The cytological and histological alterations predictive of papillomavirus infection were observed in the following proportions: For cytological changes; koilocytosis was present in 92%, bi-nucleation was observed in 24% and dyskeratosis was identified in 46%, ie 46, 12 and 23 cases, respectively, out of 50 cases of cervical neoplasia recorded. The proportions of histological alterations are presented as follows: 62% of papillomatosis, 86% of acanthosis, 54% of basal hyperplasia and 34% of intraepithelial capillaries, i.e. 31, 43, 27 and 17 cases out of respectively. The 50 cases of intraepithelial neoplasia of the cervix recorded. PD-L1 expression was observed in 16 cases out of all intraepithelial neoplasia, ie 32% of cases. PD-L1 is mainly expressed in high-grade intraepithelial neoplasias, i.e. 81.25% 95% CI=54.35-95.95 and those involving bi-nucleation (OR=26.66 95% CI=4, 63-153.57, Fisher exact, p<0.01), the intraepithelial capillaries or 37.5%; 95% CI=15.20-64.57. It emerges from this study the expression of PD-L1 is not uniform over all the cyto-histological alterations predictive of human papillomavirus infection during neoplasias. intraepithelial of the cervix, but it is much more expressed in high-grade intraepithelial neoplasias and in those comprising the predictive alterations of Papillomavirus infection like the bi-nucleation and the intraepithelial capillary. VL - 5 IS - 4 ER -
Information
Email: